| Aprepitant | Heron Therapeutics | ||
| 32 mg/4.4 mL Intravenous Emulsion |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
More Than 5
|
None | ||
| None | None | ||
| APONVIE is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated for the prevention of postoperative nausea and vomiting (PONV) in adults. | |||
|
Yes
| |||
| Aponvie | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ***** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) |
| **** ****** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ******** ************ ** ********** | ******** ************ ** ** **-* ******** ********** *** **** ******* | ******** ************ ** ********** | ******** ************ ** ** **-* ******** ********** *** **** ******* | ******* ** *** ** ******** ************ ** ** **-* ******** ********** | ******* ** *** ** ******** ************ ** ** **-* ******** ********** | ******* ** *** ** ******** ************ ** ** **-* ******** ********** | ******* ** *** ** ******** ************ ** ** **-* ******** ********** | ******** ************ ** ********** | ******** ************ ** ********** | ******** ************ ** ** **-* ******** ********** *** **** ******* | ******** ************ ** ********** | ******** ************ ** ********** |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ***** | *** \ ********* | *** **, **** | ******* | **** | ** **** *, **** |
| **** ****** | ** \ ** | *** **, **** | ******* | **** | ****** ** *** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|